Teligent EBITDA 2010-2021 | TLGT
Teligent ebitda from 2010 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Teligent Annual EBITDA
(Millions of US $) |
| 2020 |
$-126 |
| 2019 |
$5 |
| 2018 |
$-0 |
| 2017 |
$2 |
| 2016 |
$15 |
| 2015 |
$6 |
| 2014 |
$5 |
| 2013 |
$0 |
| 2012 |
$-2 |
| 2011 |
$-2 |
| 2010 |
$-3 |
| 2009 |
$-3 |
Teligent Quarterly EBITDA
(Millions of US $) |
| 2021-06-30 |
$-10 |
| 2021-03-31 |
$-8 |
| 2020-12-31 |
$-106 |
| 2020-09-30 |
$-5 |
| 2020-06-30 |
$-1 |
| 2020-03-31 |
$-15 |
| 2019-12-31 |
$-3 |
| 2019-09-30 |
$3 |
| 2019-06-30 |
$4 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
$-2 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$-1 |
| 2018-03-31 |
$0 |
| 2017-12-31 |
$-3 |
| 2017-09-30 |
$-4 |
| 2017-06-30 |
$4 |
| 2017-03-31 |
$6 |
| 2016-12-31 |
$3 |
| 2016-09-30 |
$3 |
| 2016-06-30 |
$4 |
| 2016-03-31 |
$4 |
| 2015-12-31 |
$0 |
| 2015-09-30 |
$2 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$5 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$-0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$-0 |
| 2013-03-31 |
$-0 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-0 |
| 2012-06-30 |
$-0 |
| 2012-03-31 |
$-1 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-0 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
$-1 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$-1 |
| 2009-06-30 |
$-0 |
| 2009-03-31 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
